In summary, our study suggests that serum GP73 and PKM2 are specific biomarkers for HCC diagnosis and therapy and that the secretion of GP73 and PKM2 promotes HCC progression and drug resistance by promoting angiogenesis and M2-like macrophage polarization. The gene discussed is PKM; the disease is hepatocellular carcinoma.